APA (7th ed.) Citation

Toral, K. J., Wuenschel, M. A., & Black, E. P. (2021). Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Toral, Keller J., Mark A. Wuenschel, and Esther P. Black. Genomic Data from NSCLC Tumors Reveals Correlation Between SHP-2 Activity and PD-L1 Expression and Suggests Synergy in Combining SHP-2 and PD-1/PD-L1 Inhibitors. Public Library of Science (PLoS), 2021.

MLA (8th ed.) Citation

Toral, Keller J., et al. Genomic Data from NSCLC Tumors Reveals Correlation Between SHP-2 Activity and PD-L1 Expression and Suggests Synergy in Combining SHP-2 and PD-1/PD-L1 Inhibitors. Public Library of Science (PLoS), 2021.